Home Blog Page 1780

Sentorise Launches the 12.8V 100AH Group31: Reliable, Sustainable Power for Europe


BERLIN, GERMANY – Media OutReach Newswire – 16 October 2025 – Sentorise has launched its 12.8V 100Ah Group 31 LiFePO₄ battery in Europe, providing a reliable power solution for RV travelers, off-grid homes, and marine users. With long life, built-in safety, and smart monitoring, it’s designed for dependable off-grid and backup energy.

It’s the first in Europe to offer full-series low-temperature protection and Bluetooth as standard, ensuring performance in all conditions. To reduce environmental impact, Sentorise also uses eco-friendly molded pulp packaging, proving that reliable energy doesn’t have to come at the planet’s expense.

Advanced Protection and Long Life

The Group31 is built with Grade A+ Cells and an advanced Battery Management System (BMS) that protects against overcharge, over-discharge, overcurrent, short circuits, and temperature risks. These built-in safeguards keep the battery safe to use and help extend its lifespan.

The Group31 offers an impressive cycle life under rated test conditions: over 4,000 cycles at 100% depth of discharge, 6,000 at 80%, and up to 15,000 at 60%. This makes it far more durable than conventional batteries. With an IP65 waterproof and dustproof rating, it is built for harsh environments, including humid coastlines, damp storage areas, and rugged outdoor conditions.

Supporting Sustainability in the Energy Transition

The Group31 is designed to last significantly longer than traditional lead-acid batteries, meaning fewer replacements and less waste in landfills.

Unlike lead-acid units, it is lighter, offers a much higher usable depth of discharge, and delivers lower lifetime cost. By providing consistent power output over time, it reduces both environmental impact and total ownership costs. For households and travelers who care about sustainability, this balance of performance and responsibility makes the Group31 a practical choice.

Confidence in Every Situation

The launch of the Group31 highlights Sentorise’s commitment to Europe’s energy transition with storage solutions built for safety, durability, and sustainability. From road trips and yacht excursions to everyday home backup, the Group31 provides reliable energy wherever it is needed, keeping users connected and secure in any setting.

Stay Powered. Stay Free.

Hashtag: #Sentorise

The issuer is solely responsible for the content of this announcement.

About Sentorise

Sentorise delivers advanced battery solutions for life beyond the grid. Focused on safety, durability, and sustainability, the brand empowers RV owners, campers, and off-grid families with dependable energy wherever they go.

For more information, please visit our official website: .

“Veterinary Orthopedic Guardian”: European Veterinary Surgeon Dr. Hannah Partners With VEC Hong Kong

Bringing Extensive European Experience to Lead Advanced Orthopaedic Surgeries and Elevate Pet Surgical Care


HONG KONG SAR – Media OutReach Newswire – 16 October 2025 – Veterinary Emergency Centre, Hong Kong (VEC) today announces the enhancement of its advanced orthopaedic services to further meet the local demand for advanced surgical care for pets. The centre’s orthopaedic surgeries will be led by Dr. Hannah Holmes, a senior veterinarian with over 20 years of international experience. Combining her expertise with VEC’s advanced diagnostic equipment and 24-hour critical care team, the service is dedicated to providing more precise and comprehensive treatment plans for pets suffering from bone and joint issues, helping them overcome pain and regain their vitality.

"Veterinary Orthopedic Guardian": European Veterinary Surgeon Dr. Hannah Partners With VEC Hong Kong. Bringing Extensive European Experience to Lead Advanced Orthopaedic Surgeries and Elevate Pet Surgical Care.

As a leading veterinary institution in Hong Kong, VEC has long provided 24-hour emergency, critical care, surgical, general practice, and hospitalization services. The centre is equipped with state-of-the-art medical facilities, including operating theatres, an Intensive Care Unit (ICU), a CT scanner, X-ray, and various ultrasound capabilities, ensuring the most accurate diagnoses in critical situations. Its 24-hour emergency service operates with a professional triage system to ensure that urgent cases, such as accidental fractures, are treated immediately to secure the golden hour of treatment. This round-the-clock critical care and monitoring capability provides the safest and most solid foundation for performing complex orthopaedic surgeries.

Advanced Equipment and Inter-Team Collaboration Enhance Surgical Outcomes

VEC’s orthopaedic service is built on a foundation of advanced medical technology and close team collaboration. The centre utilizes the internationally recognized Securos™ orthopaedic supplies, providing a wide range of high-quality plating systems, pins, and external fixation options for various fracture repairs and joint stabilization procedures. Before surgery, the veterinary team can use the on-site CT scanner to obtain detailed three-dimensional images, providing crucial information for creating precise surgical plans.

VEC performs well over a hundred orthopaedic and soft tissue surgeries each year, with common cases including fracture repairs and patellar luxation corrections in small-breed dogs. Dr. Hannah notes, “At VEC, orthopaedic patients benefit from the support of our ICU and hospital team. The team stabilizes critical animals before their procedures and provides intensive post-operative monitoring and care, ensuring that even our most complex cases are managed safely throughout the entire process.”

“One of the memorable cases I worked on was a young cat, Tun Tun, who arrived at our ER in critical condition after a high-rise fall, suffering from internal bleeding and multiple fractures. Thanks to the intensive care from our ICU team, against all odds, Tun Tun was stabilized and successfully underwent fracture repair surgery. The seamless collaboration of the VEC team was key to his remarkable recovery, transforming him back into a playful, mischievous cat,” shares Dr. Hannah.VEC also has a house call team that can follow up on a patient’s recovery in the comfort of their own home.

Internationally Experienced Veterinarian Joins, Infusing Professionalism and Compassion

Dr. Hannah Holmes’ arrival brings even greater professional strength to VEC’s orthopaedic services. Growing up in Scotland, Dr. Hannah graduated from the world-renowned Royal (Dick) School of Veterinary Studies in Edinburgh in 2004. Her career has taken her across the UK and Australia, .and she has also volunteered in countries with limited veterinary resources—including trips to the Cook Islands, Botswana, and Indonesia—to contribute to animal welfare, accumulating extensive experience in handling a wide variety of complex cases.

“I was drawn to the challenge of repairing what was broken and restoring function in surgery, but what truly inspires me is the transformation I see in my patients — from arriving in pain and distress to walking, running, and showing joy again after surgery,” says Dr. Hannah. She has chosen to remain a general practitioner with a surgical bias rather than a specialist, allowing her to not only perform the surgeries she loves but also to provide continuous care for her patients, building trust and relationships with pet owners. Outside of work, she is a passionate ice and rock climber. She believes the focus, precision, and problem-solving under pressure required for climbing mirror the demands of surgery, which deepens her appreciation for mobility and strength—the very things she strives to restore for her patients.

Addressing common misconceptions among pet owners, Dr. Hannah advises, “Limping is almost always a sign of pain. Animals are very good at hiding it, and even a minor limp can reflect an underlying problem that should be checked. Similarly, stiffness in older pets is not just an accepted sign of ageing. Through supplements, medication, and sometimes surgery, there is a lot we can do to significantly improve their quality of life.”

Dr. Hannah also addresses a common myth regarding brachycephalic (short-nosed) breeds like Pugs and French Bulldogs. ‘Many owners believe their dog’s noisy breathing is ‘normal for the breed.’ In fact, this noise is a sign of restricted airflow and can have serious long-term consequences. Surgery can make a huge difference—improving breathing, exercise tolerance, and overall quality of life.

Veterinary Emergency Centre (Belcher’s Street)
Address: Shop B2 & C, G/F, Luen Wai Apartments, No. 136-142 Belcher’s Street, Kennedy Town, Hong Kong.
Scope of Services: Provide 24-hour emergency, hospitalization services and veterinary housecall services. Offering professional support for urgent situations at any time.

Veterinary Emergency Centre (Davis Street)
Address: Shop C & H, G/F, Luen Gay Apartments, No. 9A-9C Davis Street, Kennedy Town, Hong Kong.
Scope of Services: Internal Medicine Specialty Service, a full range of surgical and orthopaedic procedures as well as outpatient consultations.
General Enquiries: 2334 2334
Emergency calls open 24/7: 6828 6620
WhatsApp: 5599 1144

Hashtag: #VEC #VeterinaryEmergencyCentre #PetCare #24HourEmergency #InternalMedicine #HomeVetServices #HongKongPets #PetHealth #VeterinaryServices #PetMedicalCare




The issuer is solely responsible for the content of this announcement.

Veterinary Emergency Centre (VEC)

Equipped with the latest diagnostic and treatment technologies and staffed by board-certified veterinary specialists, licensed veterinary technicians, and trained support staff, VEC provides the highest quality medical and surgical care in multiple disciplines from cardiology to acupuncture.

Aryaka Launches New Channel Program, Bringing Simplicity and Scalability to Partner Ecosystem

Aryaka Partner Program strengthens partner engagement, improves ease of onboarding, and positions company for accelerated channel-led growth


SINGAPORE – Media OutReach Newswire – 16 October 2025 – Aryaka®, the leader in and first to deliver Unified SASE as a Service, today announced the launch of a revamped channel program. The new Aryaka Parter Program delivers added simplicity, support, and structure to Aryaka’s growing Distributor and VAR ecosystem, ensuring that partners have the tools and resources to build their businesses around Aryaka solutions. The move is another significant channel milestone for Aryaka: It comes after Aryaka signed more than 30 major partners in the EMEA and APAC regions in 2025. In addition, the company has announced that Micheal McCollough, Mimecast Senior Vice President of Channels and Alliances, has joined Aryaka as a strategic advisor.

“Aryaka has always been a channel-driven company. Now, we’re doubling down on our commitment to building strong partnerships while providing the highest level of service to our joint customers,” said Nick Alagna, Vice President of Global Channels at Aryaka. “In a world transformed by AI and hybrid cloud adoption, enterprises face a growing need for secure networking. With incentives, deal sharing, improved training, simplified onboarding, and additional marketing resources, Aryaka’s partners will help us seize this opportunity.”

The new Aryaka Partner Program is structured to reward productive partners, encouraging proactive and collaborative selling. It introduces advanced programs and resources for onboarding, enablement, and demand generation to drive joint accountability.

Key features include:

  • A new tiered model offering incentive driven discounts, joint Go-To-Market planning and lead generation, and formal certification and enablement programs.
  • Formalized Market Development Funds and lucrative Sales Performance Incentive Funds to accelerate partner demand generation and incentivize channel sales teams.
  • Newly designed onboarding to help partners get to market faster and provide resources and services that deliver more value to our joint customers.

“Aryaka understands that channel success is a two-way street. That’s why we’re working hand-and-hand with our partners across the entire sales cycle, from opportunity sharing to initial discussions with prospects to delivering customers superior value through implementation and ongoing experience,” said Alagna. “The new program equips partners with the support and tools that are critical to succeed. It’s a win-win: Partners will be empowered to build profitable businesses that support Aryaka’s continued growth and rising customer demand.”

Global Channel Efforts Continue to Pay Off

Aryaka has continued to see significant global channel momentum. In the APAC and EMEA regions, the company added more than 30 new partners this year, including NTT Hong Kong, TATA Elxsi, Intensity Global Technologies, Rah Infotech, Insung Digital, IMEI, Concatenate Global Communication (HK), and M.TECH in APAC, and Brookcourt Solutions, TEEC, Hermitage Solutions, and Synax Technologies in EMEA.

“Aryaka’s Unified SASE as‑a‑Service, built on a single‑pass architecture and a Zero Trust WAN over a private backbone, aligns seamlessly with our AI‑first Telco vision,” said Rajagopalan Rajappa, Chief Technology Officer TATA Elxsi. “By combining Aryaka’s platform with Tata Elxsi’s design‑to‑deployment expertise, we will accelerate secure network transformation and deliver measurable business value at speed.”

“We are seeing enterprises across all sectors struggle to effectively manage the convergence of networking and security at scale,” said Eugene Pui, Regional Director at M.Tech. “Our partnership with Aryaka gives us a powerful new tool to help customers eliminate that complexity and accommodate the evolving demands of their businesses. Aryaka’s Unified SASE as-a-Service model makes networking and security a truly seamless, intuitive, and easy experience.”

“Crucially, this partnership is perfectly timed to address the explosive demand for unified networking and security across Southeast Asia. Aryaka Unified SASE is a genuine game-changer, and when coupled with M.Tech’s deep-rooted, reseller network and extensive expertise across the ASEAN region, we can ensure that Aryaka scales its deployment, support capabilities faster and more effectively than with any other partner.”

“We’re thrilled to partner with Aryaka. Their expertise in SD-WAN and Unified SASE complements our commitment to delivering innovative, end-to-end technology solutions that keep organizations connected, secure, and competitive,” said Phil Higgins, CEO, Brookcourt Solutions Ltd.

These new partnerships come just three months after Aryaka announced a major distributor agreement with TD SYNNEX in North America.

New Strategic Advisor Will Help Further Drive Channel Growth

Aryaka has added Mimecast Senior Vice President of Channels and Alliances Micheal McCollough as a strategic advisor. McCollough will draw on decades of channel leadership in the cybersecurity sector to help accelerate the company’s rapid global channel growth across North America, EMEA and APAC. Before joining Mimecast, McCollough led Global Channels at Anomali, Imperva, and Akamai Technologies.

“Aryaka is proving that a robust partner ecosystem is the best path to bringing their unique vision for secure networking to the market,” said McCollough. “This role is a great fit for both of us. I’m excited to leverage my cybersecurity and channel experience to help Aryaka reach more enterprises across the world.”




The issuer is solely responsible for the content of this announcement.

About Aryaka

Aryaka is the leader in delivering Unified SASE as a Service, a fully integrated solution combining networking, security, and observability. Built for the demands of Generative AI as well as today’s multi-cloud hybrid world, Aryaka enables enterprises to transform their secure networking to deliver uncompromised performance, agility, simplicity, and security. Aryaka’s flexible delivery options empower businesses to choose their preferred approach for implementation and management. Hundreds of global enterprises, including several in the Fortune 100, depend on Aryaka for their secure networking solutions. For more on Aryaka, please visit .

The National University Hospital and Ruijin Hospital, Shanghai Jiao Tong University School of Medicine establish key partnership for collaborative healthcare innovations

Through the newly-formed Singapore-Shanghai Medical Innovation Centre, clinicians from both hospitals partner to advance breakthroughs in cell and gene therapy and orthopaedics for a start

SINGAPORE – Media OutReach Newswire – 16 October 2025 – In a step towards charting a new chapter in patient-centred innovations, the National University Hospital (NUH) and the Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (RJH) formally launched the Singapore-Shanghai Medical Innovation Centre (SSMIC) on 15 October at the 6th Singapore-Shanghai Comprehensive Cooperation Council (SSCCC) meeting in Shanghai, China.

Adj Prof Mark Edward Puhaindran, Chairman, Medical Board, National University Hospital (seated, third from left) and Prof Ning Guang, President, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (seated, fourth from left), at the launch of the Singapore-Shanghai Medical Innovation Centre on 15 Oct 2025.
Adj Prof Mark Edward Puhaindran, Chairman, Medical Board, National University Hospital (seated, third from left) and Prof Ning Guang, President, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (seated, fourth from left), at the launch of the Singapore-Shanghai Medical Innovation Centre on 15 Oct 2025.

The SSMIC marks the first project arising from the Memorandum of Understanding (MOU) signed by both hospitals during the 5th SSCCC meeting in 2024 , to establish a framework for clinical cooperation through staff exchange programmes and other collaborative efforts.
Co-chaired by Professor Aymeric Lim, Chief Executive Officer of NUH, and Professor Ning Guang, President of RJH, the SSMIC will serve as a dynamic space dedicated to co-developing proof-of-concept methodologies and medical technologies, exchange of critical expertise and ideas, and conducting vital translational research.
Elevating the patient care landscape
To begin this collaborative journey, the SSMIC will focus its efforts on priority tracks that draw upon the strengths and expertise of both NUH and RJH. This focused approach aims to deliver tangible results and accelerate innovations that will directly benefit patients, beginning with:
  • Cell and gene therapy
  • 3D printing in orthopaedics
Under cell and gene therapy, cancer experts from both hospitals will jointly conduct clinical trials to validate a novel Chimeric Antigen Receptor (CAR) T-cell therapy. Using a patient’s own immunity system to fight the cancer, this therapy employs a highly personalised form of treatment to destroy the cancer cells with the specific biomarker on their surface. The objective of this collaboration is to translate the findings of the trials into a validated, effective treatment that can be made available to suitable cancer patients, especially those who have not found success with first-line cancer treatments.
In the field of orthopaedics, specialists from NUH and RJH will launch a collaborative clinical study focusing on 3D printing’s transformative potential for musculoskeletal tumour resection and reconstruction of affected areas in patients’ bodies, to enhance surgical outcomes and improve patient recovery. This includes the design and implementation of patient-specific tumour prostheses, development of advanced 3D-printed bone-ingrowth segment scaffolds, and the use of bioprinted materials to address complex reconstructive needs arising from challenging cases such as after the removal of a large tumour.
While these initial projects represent a significant first step, they are just the beginning of what SSMIC sets out for patients. With the Centre designed to be a dynamic and sustained platform, NUH and RJH will actively explore opportunities for further collaborations and expand the Centre’s scope, ensuring a sustained pipeline of clinical breakthroughs.
“In the face of ever-evolving health challenges, it is paramount that we continuously innovate and push the boundaries of medical science” said Professor Aymeric Lim. “We are honoured to formalise this partnership with RJH as we build upon the foundation of collaboration established as founding members of the Asian University Hospital Alliance and as co-hosts at the 3rd Asian University Health Forum in December this year. Through the SSMIC, we look forward to partnering with RJH with a common mission to advance real-world change in healthcare, enriching the lives of individuals in both countries and beyond.”
“NUH shares the same value with Ruijin Hospital regardless of the geographic distance so our employees will do all we can to advance the clinical care and research to benefit more patients in more countries. Clinical excellence relies on long-term investment in people and lifelong reverence for the unknown. We as physicians and surgeons shall dedicate all we learn to the new cures; and mobilise the industry, the regulators, the basic scientists and other stakeholders to apply these cures to human at the fastest speed. This is also the call of SSMIC. With the support from Shanghai government and Singapore stakeholders, I have the faith that we will succeed.” said Professor NING Guang, President of Ruijin Hospital.

Hashtag: #NationalUniversityHospital




The issuer is solely responsible for the content of this announcement.

About the National University Hospital

The National University Hospital (NUH) is Singapore’s leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.
Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.
We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.
The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore.

About Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Ruijin Hospital was founded in 1907, formerly known as “Kuang-tse Hospital 廣慈醫院” and “Hôpital Sainte-Marie”, and is a public teaching hospital of Shanghai Jiao Tong University. The hospital boasts numerous medical experts with a high reputation both at home and abroad and runs full clinical specialties in Shanghai, Zhejiang, Jiangsu and Hainan Provinces. The headquarter is located in the city center of Shanghai City where the garden campus offers assuring mental and physical care for the people. Leading with solid research accomplishment and always curing the incurable, our faculty always meets the challenges in the no man’s land of medical technology. By mastering the cutting-edge therapy and adopting the team approach, we unite our strengths for the multidisciplinary treatment on the patients.
Ruijin Hospital established the official collaboration in 2024 under the government framework between Shanghai and Singapore. This partnership marks the fruit of the long-lasting medical exchange in two cities. Aiming to tackle more unmet needs in clinical, Ruijin Hospital will join NUH for more advanced cure in Asia and beyond.

Marc Walther, President and CEO of Impact Fusion Files a Patent Pending Related to Artificial Insemination of Mammals

Napoleonville, Louisiana – Newsfile Corp. – October 15, 2025 – Impact Fusion (OTCID: IFUS) announced today, that Marc Walther, President and CEO filed a Patent Pending on Thursday October 9, 2025 with the USPO related to the artificial insemination of mammals. Impact Fusion Artificial Insemination Technology™ (Impact Fusion AIT™) is available now.

“I have long been aware of the importance of dairymen and cattle ranchers being able to have access to reliable, cost effective and safe artificial insemination of their heifers.

The size of the market in the USA alone, according to Precedence Research (Bovine Artificial Insemination Market Size to Hit USD 5.97 billion by 2034 (precedenceresearch.com) is currently valued at $3.42 billion USD in 2025. “The North America market (the largest market in the world) surpassed USD 930 million in 2024. The Asia Pacific market is expected to expand at the fastest CAGR of 7.3% during the forecast period.”

According to Grand View Research (Bovine Artificial Insemination Market Size, Share Report 2030 (grandviewresearch.com)) the Indian government approved a plan to grant up to USD $5.99 to farmers for every bovine artificial insemination they undertake. They reached out to 2,500,000 cattle farmers with a budget of USD $44 million.

Over the past few years, it has been brought to my attention by cattle ranchers and dairymen, with whom I have worked while introducing our proprietary Bovine Ration Management Technology SGP+™, that the costs and challenges of propagating their herds naturally present added complexity to an already complex enterprise. I learned that often times in a financial necessity to up-breed the herd, a young heifer cannot support the weight of the bull during the breeding process. This causes undue suffering with fatal injuries to the heifer, while creating another level of financial burden on the operation. Furthermore, often times natural breeding is not effective. Our AIT™ process is designed to add to the success rate of AIP.”

The use of Artificial Insemination (AI) is dramatically on the rise being considered a safer, cost effective and results oriented method of increasing herd size. In a report dated Aug 28, 2025, 60% of the US dairy cows are bred via AI. Conception rates vary between 50% and 76%. In Brazil conception rate as low as 55% up to 87.4% is reported of the 20% of all heifers bred via AI. That percentage is expected to increase in 2025. India reports the lowest conception rate across the country as 35% as compared to other countries that average 60% or higher. These are all target markets for Impact Fusion International for all of our products.

Tests are currently being conducted on herds in US. The protocols for implementation of the process have been well defined and will, in my opinion, create positive percentage increase in successful insemination’s. The opportunities that exist, just in the USA alone, is aimed to have a dramatic impact on the breeding of mammals, not just cows but would include sheep, pigs, horses and potentially dog breeders and all mammals.

Market sizes for Bovine Artificial Insemination; Share and Trends 2025 to 2034

The global bovine artificial insemination market size is calculated at USD 3.42 billion in 2025 and is forecasted to reach around USD 5.97 billion by 2034, accelerating at a CAGR of 6.41% from 2025 to 2034. The North America market size surpassed USD 930 million in 2024 and is expanding at a CAGR of 6.58% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Bovine Artificial Insemination Market Key Takeaways

  • North America dominated the bovine artificial insemination market with the largest share of 29% in 2024.
  • Asia Pacific is expected to expand at the fastest CAGR of 7.3% during the forecast period.
  • By solution, the service segment held the biggest market share of 40% in 2024.
  • By solution, the semen segment is expected to witness the fastest growth during the projected timeframe.
  • By distribution channel, the private segment contributed the biggest market share of 56% in 2024.
  • By distribution channel, the public segment is projected to grow at a significant rate in the coming years.
  • By sector, the dairy segment held the major market share of 64% in 2024.
  • By sector, the meat segment is expected to grow at the fastest rate between 2025 and 2034.

Is Artificial Insemination Technology the Game Changer in Bovine Reproduction?

Artificial Insemination Technology (AIT™) is transforming bovine reproduction by enhancing efficiency, accuracy, and genetic advancements in breeding programs. High-merit bulls can be precisely selected with the help of machine learning models, increasing conception rates and reducing reproductive waste. Automation reduces human error and streamlines processes in herd management, embryo transfer, and semen sorting. Farmers can make data-driven breeding choices with real-time monitoring and sophisticated analytics, which ultimately increases the production of meat and dairy products. As AIT™ advances, the future of bovine reproduction is becoming more innovative, profitable, and sustainable.

U.S. Bovine Artificial Insemination Market Size and Growth 2025 to 2034

The U.S. bovine artificial insemination market size was exhibited at USD 840 million in 2024 and is projected to be worth around USD 1.590 million by 2034, growing at a CAGR of 6.60% from 2025 to 2034.

North America dominated the bovine artificial insemination market by capturing the largest share in 2024. This is mainly due to the high investments in precision breeding, widespread adoption of veterinary reproductive technologies, and increased demand for improved livestock genetics. The high consumption of dairy and beef products further bolstered the regional market growth. There is a strong focus on productivity improvement and sustainability in farming practices, which prompted partnerships between dairy cooperatives and genetic companies, solidifying North America’s market leadership. Government-supported breeding initiatives and research facilities have also accelerated the development of disease-resistant cattle breeds and fertility management techniques. The region’s market is expanding thanks to the growing trend of combining artificial insemination methods with digital herd management solutions.

The Asia Pacific bovine artificial insemination market is expected to expand at the fastest CAGR during the forecast period. This is mainly due to the rising government-sponsored genetic improvement initiatives, growing awareness among farmers about the benefits of artificial insemination, and rising demand for high-quality dairy products. China and India are making significant investments in breed improvement to increase meat quality and milk yield. Large-scale artificial insemination efforts are being supported by programs like the China Dairy Herd Genetic Improvement Plan and India’s Rashtriya Gokul Mission. The rising adoption of genetic selection technologies among large-scale dairy cooperatives and the high focus on boosting milk production further contribute to regional market growth. Artificial insemination is also becoming more widespread in rural areas in the region due to government subsidies and farmer education programs.

Impact Fusion AIT™ is intended to support Best-Practice Economic Advantages like:

  • Genetic Improvements by selecting mammals with higher herd uniformity and overall herd health.
  • Cost Effective Processes that reduce purchasing and maintaining bulls, especially in large herds.
  • Reproductive Efficiency with higher success percentage
  • Disease Reduction in Herds, to include venereal disease.

“It is heart-rendering to hear from cattlemen and dairymen across the U.S. and Global community of the mounting struggles they are facing, while trying to supply food to all of us. With this in mind, I tasked members of our internal and external Scientific Team to focus on the impacts of our IFUS Product Lines so as to create a technology that can have a positive impact on IVF. Impact Fusion AIT™ is born from (1) requests from the market, (2) personal observations and experiences when I visit ranches and dairies, (3) reports of the positive impact IFUS Products and Technologies are having on birth-rates as well as the health and growth-rates of new-born calves, (4) increased colostrum and milk quality and quantity, and more,” said Marc Walther, CEO of Impact Fusion International.

  • Impact Fusion AIT™ is intended to join a family of products and technologies that provide real solutions that work in an eco-friendly, and cost-effective manner. Impact Fusion AIT™ has been reviewed and approved by veterinarians.

For more information Impact Fusion AIT™ call Marc Walther at 800-775-4130 or email at mwalther@impactfusionintl.com

www.impactfusionbrands.com/impact-fusion-artificial-insemination-process-for-mammals/
https://www.impactfusionbrands.com/product/ait-program-onboard-fee/

About Impact Fusion International Inc.
Impact Fusion International, Inc. is in the business of marketing products in the “Health and Wellness” sector of all international markets. It is the company’s mission to invent, develop and market these proprietary products worldwide for the health and wellbeing of humans and animals. The information contained in this release includes some statement that are not purely historical and that are “forward-looking statements.” Such forward-looking statements include, but are not limited to, statements regarding our and their management’s expectations, hopes, beliefs, intentions or strategies regarding the future, including our financial condition, results of operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipates,” “believes,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “might,” “plans,” “possible,” “potential,” “predicts,” “projects,” “seeks,” “should,” “would” and similar expressions, or the negatives of such terms, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this release are based on current expectations and beliefs concerning future developments and the potential effects on the parties and the corporate and administrative transactions. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and represent our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future.

Contact:
Impact Fusion International Inc.
204 Highway 1011
Napoleonville LA 70390
1-800-775-4130
Email: marc@impactfusionintl.com
Website: www.impactfusionbrands.com
Twitter: @impactfusionI

#Impact Fusion AIT™ patent #Mammal AI breeding technology #Bovine AI conception rates #Dairy herd genetic enhancement #Beef cattle reproductive efficiency #North America’s livestock AI market #Asia Pacific cattle breeding growth #India bovine AI subsidies #Brazil dairy AI adoption #U.S. cattle insemination innovation #Machine learning cattle breeding #Semen sorting for herd improvement #Biosecurity in mammal insemination #Cryopreservation livestock AI #Cost-effective dairy AI solutions #Venereal disease prevention cattle #SGP+™ supplement AI synergy #Sustainable bovine genetic selection #Genomic breeding for milk yield #Precision livestock fertility management

The issuer is solely responsible for the content of this announcement.

World Vision marks its 75th anniversary with World Vision Day , sharing the achievements of its global poverty alleviation efforts and expressing gratitude to its partners for walking alongside


HONG KONG SAR – Media OutReach Newswire – 16 October 2025 – Embarking the 75th anniversary of World Vision International, World Vision Hong Kong hosted World Vision Day on 11 October, 2025 (Saturday) at the Hong Kong Federation of Youth Groups Building in Quarry Bay. Themed “Light On, Hope Ahead”, World Vision Day featured sponsor sharing, thanksgiving ceremony, thematic talks and booth games, which successfully showcased our global achievements especially in Water, Sanitation and Hygiene (WASH), and health and nutrition. The event welcomed partners from almost 300 organisations and units.

Andrew Morley (Front row, 9th from the left), supporters and partners shared the outcome of alleviating poverty in the kick-off ceremony of World Vision Day.
Andrew Morley (Front row, 9th from the left), supporters and partners shared the outcome of alleviating poverty in the kick-off ceremony of World Vision Day.

Centered around the theme “Light On, Hope Ahead”, World Vision Day highlighted how partners joined hands with World Vision to bring transformation and new hope to vulnerable children and their communities. The opening ceremony was officiated by Andrew Morley, President and CEO of World Vision International, and Amy Fung, the Chief Executive Officer of World Vision Hong Kong. Long-term sponsor Stephen Chan and artists who have witnessed World Vision’s work — Priscilla Wong, Michelle Wai, director Benny Lau and his family, and music producer Cedric Chan — attended and shared valuable reflections.

Stephen Chan engaged in a heartfelt conversation with Andrew Morley about the tangible impact of the Child Sponsorship Programme, and the passion and motivation behind World Vision’s 75 years of work on global poverty.

Andrew Morley reiterated that urgent humanitarian needs have rocketed almost 10 times from 3 crises annually 15 years ago to 33 crises today, but international humanitarian funding remains critically insufficient, posing immense challenges for frontline relief efforts. He recalled he met an 8-year-old girl, Esther, living between southern Kenya and the border of northern Tanzania, whose parents sold her for marriage to an old man in exchange for six cows because the family was starving. Being abused by her husband, Esther escaped and failed. After a few attempts, she went to World Vision’s local office. Eventually she was adopted by foster parents and enrolled into a local school — an outcome made possible by the support of World Vision’s child sponsorship programme. Andrew Morley said he was impressed by her smile and the thankfulness in her eyes.

As a child sponsor of 6 children, Andrew Morley said every donation had the power to help vulnerable children like Esther transform their lives. “If you think what you are doing isn’t making any difference, just remember Esther,” he added. Andrew Morley also thanked Hong Kong people and partners. “To everyone, corporate partners, schools, hospitals, child sponsors, and to those who raise money for us, and those who pray for us, for all of you I would like to say thank you,” he said.

To honour their long-standing efforts in providing vital assistance and igniting hope of vulnerable communities, certificates of appreciation and plagues were presented to partners from nearly 300 organisations and units, and commemorative pins were awarded to donors showing more than 20 years of support.

Kenny, a child sponsor supporting World Vision for 12 years, recalled visiting his sponsored daughter in Bangladesh during a once‑in‑a‑century cyclone. Despite the devastation and the clean-up at home, she insisted on keeping their meeting, and Kenny felt deeply moved. “We often think donating money for a child’s education is the best option,” he reflected. “But if the community doesn’t have a school, the child still has no way to study even when there is adequate funding. It’s something I only came to understand after becoming a child sponsor.”

During the event, a live band made up of students from Ma On Shan Tsung Tsin Secondary School that participated in World Vision’s “Joint Secondary School Famine”, performed two record hits – “Amani” and “We Are One”. The golden hit “Amani” was written by the well-known local band Beyond after joining World Vision’s trip to Kenya in 1991, while “We Are One” was the theme song created for “30-Hour Famine” by another local band RubberBand, following their visit to Zimbabwe. Both songs conveyed messages of hope for world peace and solidarity. The event was further uplifted when 24 children of Benji’s Choir with speech impairments performed “This Little Light of Mine”, a song World Vision’s founder Dr. Bob Pierce taught children in Xiamen in 1947.

World Vision has been actively promoting the concept of legacy giving, which enables donors to bring long-term change to the fragile communities through early planning of personal assets. A seminar was co-hosted with “ForeverGift.hk” on 3 Instruments of Peace on World Vision Day, where a practicing lawyer explained the importance of making a will and enduring power of attorney, as well as making advance medical directives. Over 100 people attended the seminar.

Moreover, World Vision reaffirmed its commitment to serving the world’s most vulnerable children and communities and contributing to the Sustainable Development Goals (SDGs) via five priority areas: Water, Sanitation and Hygiene (WASH), Education, Health and nutrition, Livelihoods, and Child Protection. Workshops at the event introduced educators to these work towards SDGs, and interactive game booths engaged the public on issues such as disaster relief and water resources.

Brief history of World Vision International and World Vision Hong Kong

While on a trip to China in 1947, a young American reporter and American Baptist minister, Dr Bob Pierce, met a poor girl named Baiyu (meaning white jade) during a visit in Xiamen, who was expelled by her family as she wanted to go to school. Pierce wanted to help this precious soul, so he gave Ms Tena Hoelkedoer, a female missionary in Xiamen, all that he had, which was just five dollars. Ms Tena used it to buy food and clothes for Baiyu and send her to school. Afterwards, Pierce sent the same amount each month after returning home so that she could continue to look after Baiyu.

This encounter marked the turning point in Pierce’s life. In 1950, he founded World Vision, with the aim of helping poverty-stricken children around the world. That five dollars set the prototype of the Child Sponsorship Programme. The first Child Sponsorship Programme began a few years later in response to the needs of hundreds of thousands of orphans at the end of the Korean War in 1953. It was later extended to other Asian countries, and places such as Latin America, Africa, Eastern Europe and the Middle East.

In 1962, Typhoon Wanda hit Hong Kong severely. World Vision distributed relief supplies in Hong Kong, and later set up its first field office in the territory. With the economic recovery in Hong Kong, World Vision Hong Kong turned itself into a fundraising office in 1982, supporting the relief and development work of World Vision offices worldwide. World Vision Hong Kong also promotes public education, raising public awareness about global issues such as poverty, hunger, health and child rights.

Hashtag: #WorldVision

The issuer is solely responsible for the content of this announcement.

Miroma Project Factory wins Australia’s International Good Design Awards for Excellence in Design and Innovation for StandingTall.

SYDNEY, Oct. 16, 2025 /PRNewswire/ — The Australian Good Design Awards, one of the world’s longest-running international design award programs, has announced this year’s Winner of the Australian Good Design Award for Rewarding, Defining, and Celebrating Good Design.

Miroma Project Factory wins the Australian Good Design Award for Social Impact, empowering older Australians to live actively and age healthier.
Miroma Project Factory wins the Australian Good Design Award for Social Impact, empowering older Australians to live actively and age healthier.

This year’s theme, “Design for Better“, underscores the vital role design plays in shaping a more balanced, inclusive, and sustainable world. From reimagining products and services to reshaping cities and systems, the Awards showcase how design has the power to drive positive change for people, planet, and prosperity.

 “We are incredibly proud that StandingTall: Live Actively, Age Healthier has been recognised with a Good Design Award in the Social Impact category. This accolade reflects years of collaboration with Professor Kim Delbaere, NeuRA and UNSW to translate world-class research into a warm, accessible, and life-changing tool for older Australians. As the Commercial Lead on this project since its inception, I am personally thrilled to see the impact of our work recognised at this level. At Miroma Project Factory (MPF), we believe design is at its best when it empowers independence and wellbeing, and StandingTall is proof of how technology and thoughtful design can deliver measurable impact at scale.” Kat Robinson CEO MPF

StandingTall: Live Actively, Age Healthier, recognised as the Winner of the prestigious Australian Good Design Award Winner accolade in the Social Impact category.

“StandingTall empowers older Australians with a science-backed tablet app delivering tailored balance exercises, proven to reduce falls by 16% and injurious falls by 20%. In partnership with NeuRA and UNSW, clinical protocols have been translated into an engaging, warm design that inspires independence at home. Smart, innovative and impactful health design.” Jury Comments

Record-Breaking Year for Design Excellence

Rachel Wye, Managing Director of Good Design Australia, reflects on the calibre of this year’s entries: “The standard of Award Winners in this year’s Australian Good Design Awards was the highest on record, with game-changing projects that push the envelope of good design, design innovation and design impact. These Awards clearly demonstrate the transformational power of design to create a better and more sustainable future.”

About the Australian Good Design Awards

The Awards recognise design excellence from around the world, across 13 Design Disciplines and more than 35 categories, spanning the built environment, product design, engineering, digital, social impact, policy design and many more categories.

The 2025 Australian Good Design Awards Ceremony will take place on Friday 17 October, at the International Convention Centre (ICC) Sydney, where more than 1,000 distinguished guests from design, architecture, engineering, and business sectors will come together to celebrate the transformational power of good design.

Each entry undergoes a rigorous evaluation by over 80 international Jurors, assessed against three core criteria: Good Design, Design Innovation, and Design Impact. With a proud heritage dating back to 1958, the Australian Good Design Awards remain the nation’s oldest and most prestigious international design accolade, continuing to champion the critical role of design in shaping a brighter, fairer, and more sustainable future.

View the Award-Winning Project here: https://www.theprojectfactory.com/projects/st-rebrand 

 About Miroma Project Factory

Miroma Project Factory (MPF) is a multi-award-winning digital production and development studio, specialising in delivering ground-breaking interactive digital products across web, mobile, social media, and gaming platforms. As a female-led business recognised by Women Love Tech for creating an amazing workplace, MPF’s reputation is built on producing transformative solutions in health, broadcast, and entertainment, with a specialisation in gamification for behaviour change. Visit www.theprojectfactory.com to learn more. https://www.theprojectfactory.com/projects/standing-tall

For media inquiries, interviews, or partnership opportunities, please contact:

Miroma Project Factory
info@theprojectfactory.com 

The World’s Only SK hynix Leveraged Exchange Traded Product Debuts in Hong Kong Today

HONG KONG, Oct. 16, 2025 /PRNewswire/ — CSOP Asset Management Limited (CSOP), one of Asia’s premier Exchange Traded Product (ETP) issuers, announces the launch of the CSOP SK Hynix Daily (2x) Leveraged Product (stock code: 7709.HK) on the Hong Kong Stock Exchange (HKEX) on 16 October 2025. This follows the successful listing of leveraged and inverse products tracking its peer, Samsung Electronics, in May 2025. The CSOP SK Hynix Daily (2x) Leveraged Product is the world’s only leveraged exchange traded product tracking SK hynix, designed to empower investors to seize the upside of one of Korea’s most illustrious stocks during Asian trading hours.

CSOP SK Hynix Daily (2x) Leveraged Product (7709.HK)
CSOP SK Hynix Daily (2x) Leveraged Product (7709.HK)

As a major chip supplier to Nvidia, SK hynix’s revenue soared to 22.23 trillion KRW (~equivalent to 15.86 billion USD), representing an exponential 35% year-over-year surge[1]. In particular, 2025 is a banner year for SK hynix stock, with its return skyrocketed to a phenomenal 145% year-to-date[2]. Riding a wave of exuberant optimism driven by rapid AI development and the booming semiconductor industry in recent years, investors are doubling down on SK hynix with an average daily turnover of 824.90 billion KRW (~ equivalent to 588.73 million USD) in 2025[3]. Its 1-year total turnover reached 194 trillion KRW (~ equivalent to 140 billion USD), ranking #2 on Korea Exchange’s top 10 list and trailing only Samsung Electronics[4].

In order to track the two times daily performance (before fees and expenses) of the common stock of SK hynix, the product deploys a swap-based synthetic replication strategy, with listing price of about 7.8 HKD (1 USD) per unit, trading lot of 100, and management fee of 1.6% of the ETP’s net asset value per year. CSOP SK Hynix Daily (2x) Leveraged Product offers an amplified exposure with several advantages, including no margin calls, zero collateral requirements, no financing costs, transparent pricing, and capped maximum leverage.

“We are pleased to announce the listing of CSOP SK Hynix Daily (2x) Leveraged Product on the Hong Kong Stock Exchange,” Said Ms. Ding Chen, CEO of CSOP Asset Management. “As a leading ETF issuer in the dynamic APAC region with a 98% market share in leveraged and inverse products in Hong Kong, CSOP is committed to offering diversified investment options[5]. The introduction of the only SK hynix leveraged exchange traded product globally in Hong Kong offers opportunities to double gains on SK hynix’s meteoric growth in AI-driven semiconductor market.”

Tied to innovation and growth, SK hynix’s product line includes DRAM, NAND flash memory, and SRAM chips. It captured the lion’s share of DRAM market with 36% in Q2 2025, surpassing all competitors[6]. From 2020 to 2024, the compound annual growth rate (CAGR) of its yearly revenue, operating income, and net income reached 20%, 54%, and 58%[7]. Leading the charge in semiconductor, SK hynix is ambitiously growing into a full stack AI memory provider. SK hynix has expanded into the NAND business through an 8.84 billion USD acquisition of Intel’s NAND business in March 2025[8]. Additionally, SK hynix unveiled a spending plan to keep pace with the HBM market expansion. TrendForce reported that SK hynix’s 2025 capex is set to reach 23.44 trillion KRW (~equivalent to 16.97 billion USD), a striking 30% upswing over prior forecasts[9].

About CSOP Asset Management
For over a decade, CSOP has successfully established itself as one of the leading ETF issuers in Hong Kong, with second largest AUM and demonstrated innovative product development. As of 30 September 2025, the total AUM of CSOP reached 28.6 billion USD by building a healthy ETF ecosystem and managing 62 ETPs and 4 mutual funds in Hong Kong and Singapore markets*. In 2025, 5 out of the top 10 most actively traded ETFs/ETPs in Hong Kong are managed by CSOP**.

Asia’s First batch of Single Stock Leveraged & Inverse Products on HKEX

Product Name

HKD counter

USD counter

CSOP NVIDIA Daily (2x) Leveraged Product

7788.HK

9788.HK

CSOP NVIDIA Daily (-2x) Inverse Product

7388.HK

9388.HK

CSOP Tesla Daily (2x) Leveraged Product

7766.HK

9766.HK

CSOP Tesla Daily (-2x) Inverse Product

7366.HK

9366.HK

CSOP Coinbase Daily (2x) Leveraged Product

7711.HK

9711.HK

CSOP Coinbase Daily (-2x) Inverse Product

7311.HK

9311.HK

CSOP MicroStrategy Daily (2x) Leveraged Product

7799.HK

9799.HK

CSOP MicroStrategy Daily (-2x) Inverse Product

7399.HK

9399.HK

CSOP Berkshire Daily (2x) Leveraged Product

7777.HK

9777.HK

CSOP Samsung Electronics Daily (2x) Leveraged Product

7747.HK

9747.HK

CSOP Samsung Electronics Daily (-2x) Inverse Product

7347.HK

9347.HK

*Source: CSOP
** Source: Bloomberg, from 1 January 2025 to 30 June 2025

Disclaimer and Important Notices

NONE OF THE SUB-FUND (“SUB-FUND”) MENTIONED IN THIS DOCUMENT OR MARKETING MATERIAL (THIS “DOCUMENT”), CSOP LEVERAGED AND INVERSE SERIES AND CSOP ASSET MANAGEMENT LIMITED (“CSOP”) ARE AFFILIATED WITH THE CORRESPONDING COMPANY OF THE UNDERLYING SECURITY OF THE SUB-FUND (THE “CORRESPONDING COMPANY”).

The Corresponding Company do not sponsor or endorse the offering of the Sub-Fund, nor is it involved with the Sub-Fund in any way. Investing in the Sub-Fund is not equivalent to investing in the Corresponding Company. Investors have no ownership rights in the Corresponding Company. Investors in the Sub-Fund will not have voting rights and will not be able to influence management of the Corresponding Company but will be exposed to the performance of the relevant security of the Corresponding Company.

This document is for general information only and does not constitute any kind of advice in any way and shall not be considered as an offer or solicitation to deal in any investment products. If you wish to receive advice on investment, please consult your professional legal, tax and financial advisers.

Investment involves risks. Investors should refer to the Prospectus and the Product Key Facts Statement for further details, including product features and risk factors. Investors should not make investment decisions based on this document alone. This document is not applicable in jurisdictions where the distribution of this document is restricted.

This document is not legally binding. CSOP takes no responsibility for the contents of this document and expressly disclaim any liability for any loss arising from or in reliance upon the whole or any part of the contents of this Document. This document does not confer upon the recipient any copyright or intellectual property rights (whether direct, indirect, or implied) in the use of the information contained herein. Any information or any part of this document should not be copied, reproduced, or distributed to any parties without the written consent of CSOP.

The Sub-Fund is a leveraged product. It is different from conventional exchange traded funds as it seeks leveraged investment results relative to the underlying stock and only on a daily basis.

The Sub-Fund is concentrated in a single underlying stock. Given the non-diversified and leveraged nature, the Sub-Fund is subject to extreme price volatility and may become non-viable within a short period. You may lose a significant portion or all of your investment within one day. Under exceptional circumstances where the Sub-Fund becomes non-viable, CSOP may use its discretion to deviate from the investment strategy or take defensive measures, which may include liquidating swap positions and suspending trading of the Sub-Fund and CSOP will issue a notice to inform investors.

The Sub-Fund is not intended for holding longer than one day as the performance of the Sub-Fund over a longer period may deviate from and be uncorrelated to the leveraged performance of the underlying stock over the period.

The Sub-Fund is designed to be used for short term trading or hedging purposes, and is not intended for long term investment.

The Sub-Fund only targets sophisticated trading-oriented investors who understand the potential consequences of seeking daily leveraged results and the associated risks and constantly monitor the performance of their holdings on a daily basis.

This document is prepared and issued by CSOP and has not been reviewed by the SFC in Hong Kong.

[1] Source: Bloomberg, as of Q2 2025.

[2] Source: Bloomberg, as of 15 October 2025.

[3] Source: Bloomberg, as of 31 July 2025.

[4] Source: Korea Exchange, 30 August 2024-29 August 2025.

[5] Source: Bloomberg, 1 January 2025-30 June 2025. 

[6] Source: TrendForce.

[7] Source: SK hynix.

[8] Source: Nikkei Asia.

[9] Source: Bloomberg, as of 9 September 2025.